Laws and Ethical Issues Related to Flu Research

The Secretary of the Department of Health and Human Services has responsibility for preventing the introduction, transmission, and spread of communicable diseases in the United States. In IPR studies patent applications covering the virus itself, vaccines, treatment and diagnostics. Clinical studies of influenza involves development of drugs for the treatment  and/or prophylaxis of illness caused by influenz a viruses A and B, including both seasonal and  pandemic varieties. Sponsors considering development of antiviral drugs for the treatment or prophylaxis of disease with novel influenza strains, or in a pandemic influenza setting, are encouraged to consult this guidance and to communicate with the FDA through the pre-investigational new drug application (pre-IND) consultation program and frequently throughout drug development.

The influenza pandemic provides an opportunity for policymakers to reconsider the benefits of mandating influenza vaccination for health care workers, including building public trust, enhancing patient safety, and strengthening the health care workforce. Health care organizations have enacted a variety of vaccination policies and interventions to guard against the known hazards of nosocomial influenza transmission, including longer patient stays, absenteeism, interruptions in health care delivery, and inpatient death. Health care standards may need to be modified to respond to the public health threat and to the imbalance between the care that is needed and the resources that are available.

  • IPR studies in influenza research
  • IPR studies in influenza vaccines, therapeutics and diagnostics
  • Clinical trials in influenza treatment
  • Ethical issues in pandemic influenza planning
  • Influenza research and animal models

Related Conference of Laws and Ethical Issues Related to Flu Research

March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
May 30-31, 2018

Global experts meet on STD-AIDS and Infectious Diseases

Auckland, New Zealand
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
July 26-27, 2018

11th Global Infections Conference

Melbourne, Australia
August 20-21, 2018

Annual Meeting on Infectious Diseases

Prague, Czech Republic
August 20-21, 2018

Global HIV/AIDS Congress

Prague, Czech Republic
August 27-28, 2018

9th International Conference on Emerging Infectious Diseases

Zurich, Switzerland
August 27-29, 2018

Gulf Congress on Rare Diseases

Dubai, UAE
August 29-30, 2018

5th International Conference on Neglected Tropical & Infectious Diseases

| Boston, Massachusetts, USA
August 29-30, 2018

5th Annual Congress on Rare Diseases and Orphan Drugs

Boston, Massachusetts, USA
August 29-30, 2018

4th Annual Congress on Infectious Diseases

Boston, Massachusetts, USA
September 03-04,2018

Global Experts Meeting on Infectious Diseases

September 17-19, 2018

8th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa
September 27-29, 2018

10thEuro-Global Conference on Infectious Diseases

Rome, Italy
October 11-12, 2018

14th World Congress on Infection Prevention and Control

Moscow, Russia
October 18-20, 2018

World Polycystic Ovarian Syndrome Congress

Abu Dhabi, UAE
November 07-08, 2018

3rd International Conference on Flu and Emerging Infectious Disease

Birmingham, Alabama, USA
Dec 05-06, 2018

6th International Conference On Infectious Diseases

Lisbon, Portugal

Laws and Ethical Issues Related to Flu Research Conference Speakers

Recommended Sessions

Related Journals

Are you interested in